New combo therapy shows promise for diabetic eye damage
Disease control
Completed
This study tested whether adding a second drug (B55R2) to a standard treatment (B55R1) works better for people with non-proliferative diabetic retinopathy, a common eye problem from diabetes. 52 adults with mild to severe disease received either the combo or the single drug for 2…
Phase: PHASE4 • Sponsor: AJU Pharm Co., Ltd. • Aim: Disease control
Last updated May 15, 2026 11:56 UTC